About
Marc Ostro has considerable experience as a researcher, entrepreneur, company executive, Wall Street analyst and financial advisor. After earning a B.S. degree in Biology from Lehigh University in 1971 and his Ph.D. degree in Biochemistry from Syracuse University in 1976, he began studying liposomes as a delivery vehicle, first as a post-doctoral student and then as an Assistant Professor of Immunology and Molecular Biology at the University of Illinois Medical School. Marc Ostro was the first to use liposomes as vehicles to deliver genetic material into cells. As a result of this work, Marc Ostro was given a Young Investigator Award by the National Institutes of Health. In 1981, he commercialized his discoveries by co-founding The Liposome Company, one of the first few biotechnology companies in history. The Liposome Company, for which Marc Ostro served as President, Vice Chairman, and Chief Science Officer, was sold for over $700 million (including contingent rights) in 2000. He pl
Position in the VCSift Database
- • 2 investors at Devon Park BioVentures are tracked.
- • 626 investors hold the General Partner role in VCSift. Marc Ostro is one of them.
- • 10,621 investors are based in New York, New York, United States.
Data sourced from 410,343 investor profiles. Updated June 2026.
Investment Focus
- Location
- New York, US
Contact Information
Find more investors like Marc
Search Investors